SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0000902664-17-002967
Filing Date
2017-07-18
Accepted
2017-07-18 16:06:12
Documents
1

Document Format Files

Seq Description Document Type Size
1 MARINUS PHARMACEUTICALS, INC. p17-1522sc13g.htm SC 13G 116812
  Complete submission text file 0000902664-17-002967.txt   118337
Mailing Address 170 N RADNOR CHESTER RD SUITE 250 RADNOR PA 19087
Business Address 170 N RADNOR CHESTER RD SUITE 250 RADNOR PA 19087 484-801-4670
MARINUS PHARMACEUTICALS INC (Subject) CIK: 0001267813 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88269 | Film No.: 17969603
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address 109 STATE STREET 5TH FLOOR BOSTON MA 02109
Business Address 109 STATE STREET 5TH FLOOR BOSTON MA 02109 617-587-7507
Granite Point Capital Management, L.P. (Filed by) CIK: 0001599562 (see all company filings)

IRS No.: 582680000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G